GeneDx Holdings Corp.
WGS
$98.01
$0.740.76%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 21.67% | 11.49% | |||
| Total Other Revenue | 365.44% | -150.60% | |||
| Total Revenue | 24.41% | 9.02% | |||
| Cost of Revenue | 1.36% | 5.36% | |||
| Gross Profit | 38.40% | 11.37% | |||
| SG&A Expenses | 0.72% | 3.39% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 1.42% | -11.44% | |||
| Total Operating Expenses | 0.58% | 4.38% | |||
| Operating Income | 235.12% | 26.51% | |||
| Income Before Tax | 164.77% | 71.53% | |||
| Income Tax Expenses | 48.94% | 75.26% | |||
| Earnings from Continuing Operations | 165.42% | 71.51% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 165.42% | 71.51% | |||
| EBIT | 235.12% | 26.51% | |||
| EBITDA | 921.79% | 65.58% | |||
| EPS Basic | 163.79% | 72.01% | |||
| Normalized Basic EPS | 332.33% | 72.05% | |||
| EPS Diluted | 163.79% | 72.01% | |||
| Normalized Diluted EPS | 332.33% | 72.05% | |||
| Average Basic Shares Outstanding | 2.54% | 1.80% | |||
| Average Diluted Shares Outstanding | 2.54% | 1.80% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
